Table 2 Summary of data in Fig. 4.

From: Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site

TRPC5 variant

Residue in TRPC4/1/3/6/7

EA EC50 (nM)

AM237 EC50 (nM)

Wild-type

 

5.7

10.6

 Q573T

Q/F/K/K/K

260

110

 F576A

F/F/F/F/F

≥1400

No response up to 5 µM

 W577A

W/W/W/W/W

370

No response up to 5 µM